Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12925052rdf:typepubmed:Citationlld:pubmed
pubmed-article:12925052lifeskim:mentionsumls-concept:C0456909lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C0011884lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C0334094lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:12925052lifeskim:mentionsumls-concept:C0039260lld:lifeskim
pubmed-article:12925052pubmed:issue9lld:pubmed
pubmed-article:12925052pubmed:dateCreated2003-8-19lld:pubmed
pubmed-article:12925052pubmed:abstractTextThe natural history and treatment efficacy of diabetic retinopathy (DR) play important roles in the evaluation of screening. Therefore, the natural history of DR and rates of transition after treatment (including metabolic control and laser photocoagulation) from no diabetic retinopathy (NDR) to blindness were quantified.lld:pubmed
pubmed-article:12925052pubmed:languageenglld:pubmed
pubmed-article:12925052pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12925052pubmed:citationSubsetIMlld:pubmed
pubmed-article:12925052pubmed:statusMEDLINElld:pubmed
pubmed-article:12925052pubmed:monthSeplld:pubmed
pubmed-article:12925052pubmed:issn0742-3071lld:pubmed
pubmed-article:12925052pubmed:authorpubmed-author:WilliamsRRlld:pubmed
pubmed-article:12925052pubmed:authorpubmed-author:DuffyS WSWlld:pubmed
pubmed-article:12925052pubmed:authorpubmed-author:UjJJlld:pubmed
pubmed-article:12925052pubmed:authorpubmed-author:TEWR PRPlld:pubmed
pubmed-article:12925052pubmed:authorpubmed-author:ChenT H-HTHlld:pubmed
pubmed-article:12925052pubmed:authorpubmed-author:LiuW-JWJlld:pubmed
pubmed-article:12925052pubmed:authorpubmed-author:TungT-HTHlld:pubmed
pubmed-article:12925052pubmed:issnTypePrintlld:pubmed
pubmed-article:12925052pubmed:volume20lld:pubmed
pubmed-article:12925052pubmed:ownerNLMlld:pubmed
pubmed-article:12925052pubmed:authorsCompleteYlld:pubmed
pubmed-article:12925052pubmed:pagination727-33lld:pubmed
pubmed-article:12925052pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:meshHeadingpubmed-meshheading:12925052...lld:pubmed
pubmed-article:12925052pubmed:year2003lld:pubmed
pubmed-article:12925052pubmed:articleTitleAssessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan.lld:pubmed
pubmed-article:12925052pubmed:affiliationDepartment of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.lld:pubmed
pubmed-article:12925052pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12925052pubmed:publicationTypeEvaluation Studieslld:pubmed